Hybio Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥16.33 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	-92.45
Forward PE	61.63
Price to Sales TTM	CN¥21.78
Price to Book MRQ	CN¥25.19
Enterprise to Revenue	21.81
Enterprise to EBITDA	86.84

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-11.96%
Operating Margin	32.34%
Return on Assets TTM	0.89%
Return on Equity TTM	-13.37%

Income Statement

Revenue TTM	CN¥749,912,256
Revenue per Share TTM	CN¥0.82
Quarterly Revenue Growth	106.30%
Gross Profit TTM	CN¥399,753,632
EBITDA	CN¥162,241,458
Net Income to Common TTM	CN¥-89,683,648
Diluted EPS TTM	CN¥-0.10
Quarterly Earnings Growth YoY	106.29%

Balance Sheet

Total Cash MRQ	CN¥59,543,884
Total Cash per Share MRQ	CN¥0.07
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	266.71
Current Ratio MRQ	0.31
Book Value per Share MRQ	CN¥0.73

Cash Flow

Operating Cash Flow TTM	CN¥189,978,352
Levered Free Cash Flow TTM	CN¥-9,758,160

300199 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	883,241,336
Float Shares	640,906,411
Avg 10 Volume	92,153,846
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	30.95%
% Held by Institutions	1.61%

Stock Price Summary

Beta	1.08
Fifty Two Week Low	CN¥8.83
Fifty Two Week High	CN¥19.53
Fifty Two Week Change	45.75%
Day 50 MA	CN¥15.35
Day 200 MA	CN¥13.15

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	4.33%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	1.08%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2018-04-19
Last Split Factor
Last Split Date	2015-04-14